SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,171,725 | -8.3% | 42,500 | 0.0% | 0.06% | +31.2% |
| Q2 2023 | $1,277,550 | -17.0% | 42,500 | 0.0% | 0.05% | -15.8% |
| Q1 2023 | $1,539,775 | +1.6% | 42,500 | 0.0% | 0.06% | +7.5% |
| Q4 2022 | $1,515,975 | +36.1% | 42,500 | +29.2% | 0.05% | +20.5% |
| Q3 2022 | $1,114,000 | -97.6% | 32,900 | -98.9% | 0.04% | -94.6% |
| Q2 2022 | $46,562,000 | +4280.2% | 2,951,096 | +8869.9% | 0.82% | +2305.9% |
| Q1 2022 | $1,063,000 | +10.8% | 32,900 | 0.0% | 0.03% | +9.7% |
| Q4 2021 | $959,000 | +9.4% | 32,900 | 0.0% | 0.03% | +10.7% |
| Q3 2021 | $877,000 | -13.4% | 32,900 | 0.0% | 0.03% | -15.2% |
| Q2 2021 | $1,013,000 | – | 32,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |